Cytek Biosciences Raises FY2026 Sales Guidance from $205.000M-$212.000M to $207.000M-$212.000M vs $208.767M Est
Cytek Biosciences (NASDAQ: CTKB ) raises FY2026 sales outlook from $205.000 million-$212.000 million to $207.000 million-$212.000 million vs $208.767 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.